dc.contributor.advisor |
Callagher, L |
en |
dc.contributor.advisor |
Balmer, T |
en |
dc.contributor.advisor |
Catchpole, O |
en |
dc.contributor.advisor |
Chadderton, TC |
en |
dc.contributor.author |
Yang, Shelley |
en |
dc.date.accessioned |
2015-05-20T01:32:58Z |
en |
dc.date.issued |
2014 |
en |
dc.identifier.citation |
2014 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/25584 |
en |
dc.description |
Full text is available to authenticated members of The University of Auckland only. |
en |
dc.description.abstract |
The nutraceutical industry is growing and there appears to be no dominant strategy for commercialisation of nutraceuticals in the literature. There are also many challenges for commercialising nutraceuticals, one of the challenges is the bioavailability of the phenolic compounds (Espín et al., 2007; Haller, 2010), and the lack of regulatory definition. Considering the issues of commercialising nutraceuticals creates problems for nutraceutical producers. The purpose of this study was to determine ‘How do market and regulatory factors influence strategies for commercialisation of polyphenol-rich nutraceutical products?’ A qualitative research method in the form of two case studies (olive pomace polyphenol extract and feijoa fruit polyphenol extract) were used. Data had been gathered through secondary sources in an explicit search string method, and focused number of findings were coded out for data analysis. The findings from this study show that market (including competitor strategies and consumer behavior trends) and regulatory factors have great influence on strategies for commercialisation of both polyphenol extract products in this study. The olive pomace polyphenol extract had more chances of having health claims, primarily due to EFSA’s regulatory approval and established scientific studies. Whereas, the feijoa polyphenol extract is subject to the requirements of regulatory bodies in different countries. The implication for the commercialisation of nutraceuticals were the ability to differentiate the product when there are no health claims. The consideration of competitors are necessary to determine the forces that influenced the market. Where feijoa polyphenol extract had greater supplier bargaining power over buyers as opposed to the olive pomace polyphenol extract. The limitations addressed in this study involved the inability to generalise the specific case studies, the changes that could occur for regulations, the limitation to the scope of the study and methodology. Possible future research could be used to encourage more effective ways at strategies for commercialisation by looking at other areas of the commercialisation process. The conceptual framework developed in this study can determine how market and regulatory factors influence strategies for commercialisation, in which these insights could be used to address the challenges of commercialising nutraceuticals. |
en |
dc.publisher |
ResearchSpace@Auckland |
en |
dc.relation.ispartof |
Masters Thesis - University of Auckland |
en |
dc.relation.isreferencedby |
UoA99264780411402091 |
|
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights |
Restricted Item. Available to authenticated members of The University of Auckland. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.rights.uri |
http://creativecommons.org/licenses/by-nc-sa/3.0/nz/ |
en |
dc.title |
Commercialisation strategies for polyphenol-rich products from horticultural co-product streams |
en |
dc.type |
Thesis |
en |
thesis.degree.grantor |
The University of Auckland |
en |
thesis.degree.level |
Masters |
en |
dc.rights.holder |
Copyright: The Author |
en |
pubs.elements-id |
487380 |
en |
pubs.record-created-at-source-date |
2015-05-20 |
en |
dc.identifier.wikidata |
Q112907757 |
|